Fmr LLC Nuvation Bio Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Fmr LLC holds 51,039,313 shares of NUVB stock, worth $185 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

51,039,313

Previous 50,599,225 0.87%

Holding current value

$185 Million

Previous $89.1 Million 11.76%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.66 - $2.53 $730,546 - $1.11 Million	440,088 Added 0.87%	51,039,313 $99.5 Million
Q1 2025 May 12, 2025	BUY	$1.76 - $3.25 $9.35 Million - $17.3 Million	5,313,653 Added 11.73%	50,599,225 $89.1 Million
Q4 2024 Feb 13, 2025	BUY	$2.01 - $3.01 $32.3 Million - $48.3 Million	16,046,701 Added 54.88%	45,285,572 $120 Million
Q3 2024 Nov 13, 2024	BUY	$2.3 - $3.83 $958,943 - $1.6 Million	416,932 Added 1.45%	29,238,871 $67.2 Million
Q2 2024 Aug 13, 2024	BUY	$2.58 - $3.69 $2.8 Million - $4 Million	1,084,862 Added 3.91%	28,821,939 $84.2 Million
Q1 2024 May 13, 2024	BUY	$1.46 - $3.97 $2.35 Million - $6.38 Million	1,606,418 Added 6.15%	27,737,077 $101 Million
Q4 2023 Feb 13, 2024	SELL	$0.96 - $1.53 $6.29 Million - $10 Million	-6,554,257 Reduced 20.05%	26,130,659 $39.5 Million
Q3 2023 Nov 13, 2023	BUY	$1.26 - $2.1 $18,091 - $30,151	14,358 Added 0.04%	32,684,916 $43.8 Million
Q2 2023 Aug 11, 2023	BUY	$1.56 - $1.84 $118 - $139	76 Added 0.0%	32,670,558 $58.8 Million
Q1 2023 May 11, 2023	BUY	$1.6 - $2.48 $9.83 Million - $15.2 Million	6,143,517 Added 23.16%	32,670,482 $54.2 Million
Q4 2022 Feb 13, 2023	SELL	$1.68 - $2.5 $5.58 Million - $8.31 Million	-3,322,498 Reduced 11.13%	26,526,965 $50.9 Million
Q3 2022 Nov 10, 2022	SELL	$0.29 - $4.04 $590,314 - $8.22 Million	-2,035,568 Reduced 6.38%	29,849,463 $66.9 Million
Q2 2022 Aug 12, 2022	BUY	$3.24 - $5.85 $927,624 - $1.67 Million	286,304 Added 0.91%	31,885,031 $103 Million
Q1 2022 May 13, 2022	SELL	$4.6 - $8.83 $309,639 - $594,373	-67,313 Reduced 0.21%	31,598,727 $166 Million
Q4 2021 Feb 14, 2022	SELL	$7.75 - $10.05 $3.6 Million - $4.66 Million	-464,134 Reduced 1.44%	31,666,040 $269 Million
Q3 2021 Nov 15, 2021	SELL	$7.78 - $10.0 $4.02 Million - $5.17 Million	-517,297 Reduced 1.58%	32,130,174 $319 Million
Q2 2021 Aug 13, 2021	BUY	$9.22 - $14.48 $301 Million - $473 Million	32,647,471 New	32,647,471 $304 Million

Others Institutions Holding NUVB

# of Institutions

195

Shares Held

168M

Call Options Held

2.31M

Put Options Held

221K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $789M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account